Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05669911

Development of a Self-collection Device for Cervical Cancer Screening

Pilot Study: Evaluation of a Novel Self-Collection Device for Cervical Cancer Screening

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
235 (actual)
Sponsor
Teal Health, Inc. · Industry
Sex
Female
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

Evaluation of a novel self-collection device for cervical cancer screening.

Detailed description

The purpose of this study is to collect design and user input on the safety and effectiveness of the Teal Health self-collection device for patient self-collection of cervicovaginal samples for use with FDA-approved in vitro diagnostics indicated for high risk Human Papillomavirus (hrHPV) screening.

Conditions

Interventions

TypeNameDescription
DEVICETeal Health Self-Collection Device GroupParticipants will use the Instructions for Use to perform self-collection of cervicovaginal cells using the Teal Health Self-Collection Device, and will fill out a usability survey and a satisfaction and needs survey. A Pap smear will be performed by a clinician before or after self-collection.

Timeline

Start date
2022-08-28
Primary completion
2023-11-06
Completion
2023-12-31
First posted
2023-01-03
Last updated
2023-11-02

Locations

6 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05669911. Inclusion in this directory is not an endorsement.

Development of a Self-collection Device for Cervical Cancer Screening (NCT05669911) · Clinical Trials Directory